Biography
Mark started as a developmental biologist working on transcription factors controlling flower shape and color. Then came to America and worked at Berkeley and Stanford on genes no one but maize people really care about. He moved from Academia to Industry just as the human genome was published and since then he has worked for several genomics related companies ranging from startups to global pharma. Most recently Thermofisher on FDAapproved diagnostic sequencing, DNAnexus on cloud genomics, and now at Tag.bio implementing question to answer analytics.
Talk
AI and Data Sciences Showcase:
Tag.bio
Tag.bio is a data analytics company that implements a cloud-based Data Mesh architecture for Healthcare and LifeSciences organizations. Our platform is implemented within your secure cloud and provides easy access to self-service analysis via a mesh of data products.
Faster discovery via Data Mesh for patients and clinical trials
Applying a modular architecture for fast, scalable, and useful multi-modal data products to Health care and LifeSciences.
The PMWC 2023 AI Company Showcase will provide a 15-minute time slot for selected AI companies to present their latest technologies to an audience of leading investors, potential clients, and partners. We will hear from companies building technologies that expedite the pre-clinical and clinical drug discovery and development process, accelerate patient diagnosis and treatment, or develop scalable systems framework to make AI and deep/machine learning a reality.